Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels
Abstract
:1. Introduction
2. Case Report
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Melmed, S. Chapter 15—Hypothalamic–Pituitary Regulation. In Conn’s Translational Neuroscience; Academic Press: Cambridge, MA, USA, 2017. [Google Scholar]
- Bronstein, M.D. Prolactinomas and Pregnancy. Pituitary 2006, 8, 31–38. [Google Scholar] [CrossRef] [PubMed]
- Yatavelli, R.K.R.; Bhusal, K. Prolactinoma. In StatPearls; StatPearls Publishing: Tampa, FL, USA, 2018. Available online: https://www.ncbi.nlm.nih.gov/books/NBK459347/ (accessed on 20 May 2022).
- Colao, A. Pituitary tumours: The prolactinoma. Best Pract. Res. Clin. Endocrinol. Metab. 2009, 23, 575–596. [Google Scholar] [CrossRef] [PubMed]
- Prabhakar, V.K.; Davis, J.R. Hyperprolactinemia. Best Pract. Res. Clin. Obstet. Gynaecol. 2008, 22, 341–353. [Google Scholar] [CrossRef] [PubMed]
- Saleem, M.; Martin, H.; Coates, P. Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues. Clin. Biochem. Rev. 2018, 39, 3–16. [Google Scholar]
- Maiter, D. Prolactinoma and pregnancy: From the wish of conception to lactation. Ann. Endocrinol. 2016, 77, 128–134. [Google Scholar] [CrossRef]
- Cunningham, F.G.; Gant, N.F.; Leveno, K.J.; Gilstrap, L.C., III; Hauth, J.C.; Wenstrom, K.D. (Eds.) Endocrine Disorders. In Williams Obstetrics; McGraw-Hill: New York, NY, USA, 2001; Volume 50, p. 1353. [Google Scholar]
- Samperi, I.; Lithgow, K.; Karavitaki, N. Hyperprolactinaemia. J. Clin. Med. 2019, 8, 2203. [Google Scholar] [CrossRef] [Green Version]
- Melmed, S.; Casanueva, F.F.; Hoffman, A.R.; Kleinberg, D.L.; Montori, V.M.; Schlechte, J.A.; Wass, J.A.H. Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 273–288. [Google Scholar] [CrossRef]
- Leca, B.M.; Mytilinaiou, M.; Tsoli, M.; Epure, A.; Aylwin, S.J.B.; Kaltsas, G.; Randeva, H.S.; Dimitriadis, G.K. Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis. Sci. Rep. 2021, 11, 330–331. [Google Scholar] [CrossRef]
- Dawaher, W.; Patel, S.; Unjom, Z.; Moid, A.; Gilden, J.L.; Trendafilova, V. Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding. J. Endocrin. Soc. 2021, 5, A582. [Google Scholar] [CrossRef]
- Brown, R.S.; Herbison, A.E.; Grattan, D.R. Prolactin regulation of kisspeptin neurons in the mouse brain and its role in the lactation induced suppression of kisspeptin expression. J. Neuroendocrinol. 2014, 26, 898–908. [Google Scholar] [CrossRef]
- Sonigo, C.; Bouilly, J.; Carre, N.; Tolle, V.; Caraty, A.; Tello, J.; Simony-Conesa, F.J.; Millar, R.; Young, J.; Binart, N. Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J. Clin. Investig. 2012, 122, 3791–3795. [Google Scholar] [CrossRef] [PubMed]
- Majumdar, A.; Mangal, N.S. Hyperprolactinemia. J. Hum. Reprod. Sci. 2013, 6, 168–175. [Google Scholar] [CrossRef] [PubMed]
- Bernard, H.J. Evaluation of endocrine function. In Clinical Diagnosis and Management by Laboratory Methods, 20th ed.; ASM Press: Washington, DC, USA, 1998; pp. 303–304. [Google Scholar]
- Jayakrishnan, K. Chapter 11—Hyperprolactinemia and Infertility. In Insights Into Infertility Management; JP Medical Ltd.: New Delhi, India, 2011; p. 79. [Google Scholar]
- Fukuhara, N.; Nishiyama, M.; Iwasaki, Y. Update in Pathogenesis, Diagnosis, and Therapy of Prolactinoma. Cancers 2022, 14, 3604. [Google Scholar] [CrossRef]
- Al Dahmani, K.M.; Almalki, M.H.; Ekhzaimy, A.; Aziz, F.; Bashier, A.; Mahzari, M.M.; Beshyah, S.A. Proportion and predictors 344 of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists. Pituitary 2022, 25, 658–666. [Google Scholar] [CrossRef]
- Levin, G.; Rottenstreich, A. Prolactin, prolactin disorders, and dopamine agonists during pregnancy. Hormones 2019, 18, 137–139. [Google Scholar] [CrossRef]
- Caraty, A.; Martin, G.B.; Montgomery, G. A new method for studying pituitary responsiveness in vivo using pulses of LH-RH analogue in ewes passively immunized against native LH-RH. Reprod. Nutr. Dev. 1984, 24, 439–448. [Google Scholar] [CrossRef] [Green Version]
- Padmanabhan, V.; McFadden, K.; Mauger, D.T.; Karsch, F.J.; Midgley Jr, A.R. Neuroendocrine control of follicle-stimulating hormone (FSH) secretion. I. Direct evidence for separate episodic and basal components of FSH secretion. Endocrinology 1997, 138, 424–432. [Google Scholar] [CrossRef] [PubMed]
- Kaiser, U.B.; Jakubowiak, A.; Steinberger, A.; Chin, W.W. Differential effects of gonadotropin releasing hormone (GnRH) pulse frequency on gonadotropin subunit and GnRH receptor messenger ribonucleic acid levels in vitro. Endocrinology 1997, 138, 1224–1231. [Google Scholar] [CrossRef]
- Marquez, P.; Skorupskaite, K.; George, J.T.; Anderson, R.A. Physiology of GnRH and Gonadotropin Secretion. 2018. Available online: https://www.ncbi.nlm.nih.gov/books/NBK279070/36 (accessed on 22 May 2022).
- Milenkovic, L.; D’Angelo, G.; Kelly, P.A.; Weiner, R.I. Inhibition of gonadotropin hormone releasing hormone release by prolactin from GT1 neuronal cell lines through prolactin receptors. Proc. Natl. Acad. Sci. USA 1994, 91, 1244–1247. [Google Scholar] [CrossRef] [Green Version]
- Donato, J., Jr.; Frazao, R. Interreactions between prolactin and kisspeptin to control reproduction. Arch. Endocrinol. Metabol. 2016, 60, 587–595. [Google Scholar] [CrossRef] [Green Version]
- Hoskova, K.; Bryant, N.K.; Chen, M.E.; Nachtigall, L.B.; Lippincott, M.J.; Balasubramanian, R.; Seminara, S.B. Kisspeptin Overcomes GnRH Neuronal Suppression Secondary to Hyperprolactinemia in Humans. J. Clin. Endocrinol. Metab. 2022, 107, e3515–e3525. [Google Scholar] [CrossRef]
- Li, Q.; Rao, A.; Pereira, A.; Clarke, I.J.; Smith, J.T. Kisspeptin Cells in the Ovine Arcuate Nucleus Express Prolactin Receptor but not Melatonin Receptor. J. Neuroendocrinol. 2011, 23, 871–882. [Google Scholar] [CrossRef] [PubMed]
- Hrabovszky, E.; Ciofi, P.; Vida, B.; Horvath, M.C.; Keller, E.; Caraty, A.; Bloom, S.R.; Ghatei, M.A.; Dhillo, W.S.; Liposits, Z.; et al. The kisspeptin system of the human hypothalamus: Sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur. J. Neurosci. 2010, 31, 1984–1998. [Google Scholar] [CrossRef] [PubMed]
- Lehman, M.N.; Coolen, L.M.; Goodman, R.L. Minireview: Kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: A central node in the control of gonadotropin releasing hormone secretion. Endocrinology 2010, 151, 3479–3489. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Skorupskaite, K.; George, J.T.; Anderson, R.A. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum. Reprod. Update 2014, 20, 485–500. [Google Scholar] [CrossRef] [Green Version]
- Ikegami, K.; Minabe, S.; Ieda, N.; Goto, T.; Sugimoto, A.; Nakamura, S.; Inoue, N.; Oishi, S.; Maturana, A.D.; Sanbo, M.; et al. Evidence of involvement of neurone-glia/neurone-neurone communications via gap junctions in synchronised activity of KNDy neurones. J. Neuroendocrinol. 2017, 29, 1–14. [Google Scholar] [CrossRef]
- Herbison, A.E.; Skinner, D.C.; Robinson, J.E.; King, I.S. Androgen receptor-immunoreactive cells in ram hypothalamus: Distribution and co-localization patterns with gonadotropin releasing hormone, somatostatin and tyrosine hydroxylase. Neuroendocrinology 1996, 63, 120–131. [Google Scholar] [CrossRef]
- Kinsey-Jones, J.S.; Li, X.F.; Knox, A.M.; Wilkinson, E.S.; Zhu, X.L.; Chaudhary, A.A.; Milligan, S.R.; Lightman, S.L.; O’Byrne, K.T. Down-regulation of hypothalamic kisspeptin and its receptor, Kiss1r, mRNA expression is associated with stress-induced suppression of luteinizing hormone secretion in the female rat. J. Neuroendocrinol. 2009, 21, 20–29. [Google Scholar] [CrossRef]
- Wdowiak, A.; Raczkiewicz, D.; Janczyk, P.; Bojar, I.; Makara-Studzińska, M.; Wdowiak-Filip, A. Interactions of Cortisol and Prolactin with Other Selected Menstrual Cycle Hormones Affecting the Chances of Conception in Infertile Women. Int. J. Environ. Res. Public Health 2020, 17, 7537. [Google Scholar] [CrossRef]
- Backholer, K.; Smith, J.T.; Rao, A.; Pereira, A.; Iqbal, J.; Ogawa, S.; Li, Q.; Clarke, I.J. Kisspeptin cells in the ewe brain respond to leptin and communicate with neuropeptide Y and proopiomelanocortin cells. Endocrinology 2010, 151, 2233–2243. [Google Scholar] [CrossRef]
- Araujo, B.; Belo, S.; Carvalho, D. Pregnancy and Tumor Outcomes in Women with Prolactinoma. Exp. Clin. Endocrinol. Diabetes 2017, 125, 642–648. [Google Scholar] [CrossRef] [PubMed]
- Colao, A.; Abs, R.; Bárcena, D.G.; Chanson, P.; Paulus, W.; Kleinberg, D.L. Pregnancy outcomes following cabergoline treatment: Extended results from a 12-year observational study. Clin. Endocrinol. 2008, 68, 66–71. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Tang, C.; Wen, G.; Zhong, C.; Yang, J.; Zhu, J.; Ma, C. The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas. Front. Endocrinol. 2019, 9, 768. [Google Scholar] [CrossRef] [PubMed]
- Crosignani, P.G. Management of hyperprolactinemic infertility. Middle East Fert. Soc. J. 2012, 17, 63–69. [Google Scholar] [CrossRef]
- Khaldi, S.; Saad, G.; Elfekih, H.; Abdelkrim, A.B.; Ach, T.; Kacem, M.; Chaieb, M.; Maaroufi, A.; Hasni, Y.; Ach, K. Pituitary apoplexy of a giant prolactinoma during pregnancy. Gynecol. Endocrinol. 2021, 37, 863–866. [Google Scholar] [CrossRef] [PubMed]
- Souteiro, P.; Belo, S.; Carvalho, D. Dopamine agonists in prolactinomas: When to withdraw? Pituitary 2020, 23, 38–44. [Google Scholar] [CrossRef]
- Snyder, P.J. Patient Education: High Prolactin Levels and Prolactinomas (Beyond the Basics). Available online: https://www.uptodate.com/contents/high-prolactin-levels-and-prolactinomas-beyond-the-basics/contributors (accessed on 24 May 2022).
- Oride, A.; Kanasaki, H.; Okada, H.; Satoru Kyo, S. Reproductive prognosis of patients with hypogonadotropic hypogonadism: Retrospective review of 16 cases with amenorrhea. J. Obstet. Gynaecol. Res. 2021, 47, 3895–3902. [Google Scholar] [CrossRef]
- Tyson, J.E.; Hwang, P.; Guyda, H.; Friesen, H.G. Studies of prolactin secretion in human pregnancy. Am. J. Obstet. Gynecol. 1972, 113, 14–24. [Google Scholar] [CrossRef]
- Corlenblum, B. Pituitary Disease and Pregnancy. 2018. Available online: https://emedicine.medscape.com/article/127650-overview#a2 (accessed on 24 May 2022).
- Ho Yuen, B.; Cannon, W.; Lewis, J.; Sy, L.; Wooley, S. A possible role for prolactin in the control of human chorionic gonadotropin and estrogen secretion by fetoplacental unit. Am. J. Obstet. Gynecol. 1980, 136, 286–291. [Google Scholar] [CrossRef]
- Kletzky, O.A.; Marrs, R.P.; Howard, W.F.; McCormick, W.; Mishell, D.R., Jr. Prolactin synthesis and release during pregnancy and puerperium. Am. J. Obstet. Gynecol. 1980, 136, 545–550. [Google Scholar] [CrossRef]
- McCoshen, J.A.; Barc, J. Prolactin bioactivity following decidual synthesis and transport by amniochorion. Am. J. Obstet. Gynecol. 1985, 153, 217–223. [Google Scholar] [CrossRef]
- Narita, O.; Kimura, T.; Suganuma, N.; Osawa, M.; Mizutani, S.; Masahashi, T.; Asai, M.; Tomoda, T. Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma. Nihon Sanka Fujinka Gakkai Zasshi 1985, 37, 758–762. [Google Scholar] [PubMed]
- Speroff, L.; Glass, R.H.; Kase, N.G. The Endocrinology of Pregnancy. In Clinical Gynecologic Endocrinology and Infertility; Lippincott Williams& Wilkins: Philadelphia, PA, USA, 1999; Volume 8, p. 304. [Google Scholar]
- Flores-Espinosa, P. Selective immuno-modulatory effect of prolactin upon pro-inflammatory response in human fetal membranes. J. Reprod. Immunol. 2017, 123, 58–64. [Google Scholar] [CrossRef] [PubMed]
- Albrecht, B.H.; Betz, G. Prolactin-secreting pituitary tumors and pregnancy. In Contemporary Issues in Endocrinology and metabolism: Prolactinomas; Olefshy, J.M., Robinson, R.J., Eds.; Churchill Livingston: London, UK, 1986; Volume II, p. 195. [Google Scholar]
- Luger, A.; Broersen, L.H.A.; Biermasz, N.R.; Biller, B.M.K.; Buchfelder, M.; Chanson, P.; Jorgensen, J.O.L.; Kelestimur, F.; Llahana, S.; Maiter, D.; et al. ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. Eur. J. Endocrinol. 2021, 185, G1–G33. [Google Scholar] [CrossRef]
- Almalki, M.H.; Alzahrani, S.; Alshahrani, F.; Alsherbeni, S.; Almoharib, O.; Aljohani, N.; Almagamsi, A. Managing Prolactinomas during Pregnancy. Front. Endocrinol. 2015, 6, 85. [Google Scholar] [CrossRef] [Green Version]
- O’Sullivan, S.M.; Farrant, M.T.; Ogilvie, C.M.; Gunn, A.J.; Milsom, S.R. An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists. Aust. N. Z. J. Obstet. Gynaecol. 2020, 60, 405–411. [Google Scholar] [CrossRef] [PubMed]
- Glezer, A.; Bronstein, M.D. Prolactinomas: How to handle prior to and during pregnancy? Minerva Endocrinol. 2018, 43, 423–429. [Google Scholar] [CrossRef] [PubMed]
- Duhamel, C.; Ilie, M.D.; Salle, H.; Nassouri, A.J.; Gaillard, S.; Deluche, W.; Assaker, R.; Mortier, L.; Cortet, C.; Raverot, G. Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature. J. Pers. Med. 2020, 10, 88. [Google Scholar] [CrossRef]
- Kuhn, E.; Weinreich, A.A.; Biermasz, N.R.; Jorgensen, J.O.L.; Chanson, P. Apoplexy of microprolactinomas during pregnancy: Report of five cases and review of the literature. Eur. J. Endocrinol. 2021, 185, 99–108. [Google Scholar] [CrossRef]
- Crosignani, P.G.; Mattei, A.M.; Severini, V.; Cavioni, V.; Maggioni, P.; Testa, G. Long-term effects of time, medical treatment and pregnancy in 176 hyperproactinemic women. Eur. J. Obstet. Gynecol. Reprod. Biol. 1992, 44, 175–180. [Google Scholar] [CrossRef]
- Domingue, M.E.; Devuyst, F.; Alexopoulou, O.; Corvilain, B.; Maiter, D. Outcome of prolactinoma after pregnancy and lactation: A study on 73 patients. Clin. Endocrinol. 2014, 80, 642–648. [Google Scholar] [CrossRef] [PubMed]
- Badawy, S.Z.; Marziale, J.C.; Rosenbaum, A.E.; Chang, J.K.; Joy, S.E. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies. Early Pregnancy 1997, 3, 306–311. [Google Scholar] [PubMed]
- Swanson, J.A.; Chapler, F.K.; Sherman, B.M.; Crickard, K. Spontaneous pregnancy in women with a prolactin-producing pituitary adenoma. Fert. Sterilit. 1978, 29, 629–631. [Google Scholar] [CrossRef] [PubMed]
- Eren, M.A.; Cece, H.; Torun, A.N. Spontaneous and Uneventful Pregnancy Occurring in a Case of Macroprolactinoma Diagnosed With Subclinical Pituitary Apoplexy. Neurosurg. Q. 2012, 22, 43–45. [Google Scholar] [CrossRef]
- Ennaifer, H.; Jemel, M.; Kandar, H.; Grira, W.; Kammoun, I.; Ben Salem, L. Developed diplopia due to a pituitary macroadenoma during pregnancy. Pan Afr. Med. J. 2018, 29, 39. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tica, A.A.; Dumitrescu, D.; Tica, I.; Neamţu, C.; Tica, V.I.; Dumitrescu, C.I.; Tica, O.S. Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels. J. Pers. Med. 2022, 12, 2061. https://doi.org/10.3390/jpm12122061
Tica AA, Dumitrescu D, Tica I, Neamţu C, Tica VI, Dumitrescu CI, Tica OS. Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels. Journal of Personalized Medicine. 2022; 12(12):2061. https://doi.org/10.3390/jpm12122061
Chicago/Turabian StyleTica, Andrei Adrian, Daniela Dumitrescu, Irina Tica, Corina Neamţu, Vlad Iustin Tica, Cristiana Iulia Dumitrescu, and Oana Sorina Tica. 2022. "Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels" Journal of Personalized Medicine 12, no. 12: 2061. https://doi.org/10.3390/jpm12122061
APA StyleTica, A. A., Dumitrescu, D., Tica, I., Neamţu, C., Tica, V. I., Dumitrescu, C. I., & Tica, O. S. (2022). Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels. Journal of Personalized Medicine, 12(12), 2061. https://doi.org/10.3390/jpm12122061